LMR Partners LLP Sells 15,497 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

LMR Partners LLP lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 59.3% in the third quarter, HoldingsChannel reports. The fund owned 10,615 shares of the medical equipment provider’s stock after selling 15,497 shares during the period. LMR Partners LLP’s holdings in Intuitive Surgical were worth $5,215,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of ISRG. International Assets Investment Management LLC boosted its position in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the period. Capital Research Global Investors acquired a new position in Intuitive Surgical in the first quarter valued at about $374,390,000. Strategic Financial Concepts LLC raised its stake in Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after purchasing an additional 265,461 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in Intuitive Surgical by 36.4% in the first quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider’s stock valued at $322,377,000 after purchasing an additional 215,444 shares in the last quarter. Finally, Manning & Napier Advisors LLC acquired a new position in Intuitive Surgical in the second quarter valued at about $91,466,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 396 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,680,761.28. This represents a 6.71 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Jamie Samath sold 269 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 91,178 shares of company stock worth $45,897,071. Insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of analyst reports. BTIG Research set a $535.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Raymond James boosted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Wells Fargo & Company boosted their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Trading Up 0.8 %

NASDAQ:ISRG opened at $531.64 on Tuesday. The stock has a market cap of $189.36 billion, a P/E ratio of 85.47, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock’s 50-day moving average is $500.33 and its 200-day moving average is $459.58. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.